Background
HUTT, Peter was born on November 16, 1934 in Buffalo, New York, United States. Son of Lester Ralph Hutt and Louise Rich Fraser.
( Approximately 25 cents out of every dollar spent by Ame...)
Approximately 25 cents out of every dollar spent by American consumers is for a commodity regulated by the Food and Drug Administration. The agency has jurisdiction over food, drugs, cosmetics, medical devices, biological products, animal food and drugs, and tobacco products, as well as electronic products that emit radiation and products that spread communicable disease. FDA regulation thus touches the production and sale of most products that fill the shelves of our supermarkets and drug stores and virtually every product prescribed or used by the medical profession. The agency’s responsibilities range from the simplest foods and personal care products to the most technologically sophisticated innovations of biotechnology and medical engineering. Food and Drug Law is the law governing the actions taken by FDA and its sister agencies to oversee the safety of this vast universe of products, to ensure that their labeling (and in some cases advertising) is accurate and informative, and to shepherd safe and effective new products onto the market. The book contains many court cases, but to reflect the diverse forums in which food and drug law is developed and enforced, the text also contains many other types illustrative materials: Federal Register preambles, warning letters, regulatory guidance documents, Congressional hearing testimony, scholarly articles, newspaper opinion pieces, and many others. In addition, the book offers a generous amount of original content, in which the authors guide the reader through the complexities of the statutory and regulatory scheme. Moreover, like past editions, the Fourth Edition includes numerous illuminating notes, which offer a gold mine of fascinating examples of the law in action. The Fourth Edition, like previous editions, is extraordinarily valuable for practitioners. But notably, the book has been reorganized and edited so as to make it more useful than ever for students and professors. Much important contextual material has been moved to the front of the book, so students will grasp essential administrative, jurisdictional, federalism, and enforcement issues before mastering the intricacies of the product-specific chapters. The casebook thus provides an introductory window into administrative law for students who have not yet taken the basic Administrative Law course, as well as for first year students taking Food and Drug Law as an elective. The chapter on human drugs has been thoroughly reorganized to improve its comprehensibility. Throughout the book, other changes to organization and presentation have been made with professors and students in mind. The Fourth Edition is completely updated through the early fall of 2013. It includes a new chapter on tobacco regulation to reflect the responsibilities FDA acquired under the Family Smoking Prevention and Tobacco Control of 2009. It also incorporates all the other statutory amendments since 2007 (for example, the Food and Drug Administration Act, the Food Safety Modernization Act, and the Food and Drug Administration Safety and Innovation Act). Every major development of the past six years is addressed, from the significant First Amendment cases to the preemption of tort suits to the drug compounding crisis to the regulation of bioengineered salmon.
http://www.amazon.com/gp/product/1609301757/?tag=2022091-20
(This compilation includes the completely updated Federal ...)
This compilation includes the completely updated Federal Food, Drug, and Cosmetic Act, plus selected additional federal statutes important to food and drug law. This edition is current through October, 2014 and includes the amendments made by the Drug Quality and Security Act. This Revised 2014 Edition does not reflect any substantive changes in the law since the publication of the first 2014 Edition, but rather merely corrects errors contained in the earlier edition, most of which were introduced during the production process.
http://www.amazon.com/gp/product/1634591909/?tag=2022091-20
(This compilation includes the completely updated Federal ...)
This compilation includes the completely updated Federal Food, Drug, and Cosmetic Act, plus selected additional federal statutes important to food and drug law.
http://www.amazon.com/gp/product/1609302109/?tag=2022091-20
(Food and drug law deals with governmental attempts to pro...)
Food and drug law deals with governmental attempts to protect public health and individual welfare in the development and marketing of essential commodities. The materials included in this Third Edition, the organization used, and the issues dealt with reflect this focus. The organization and bibliographic assistance should help frame the pertinent questions and identify many of the relevant sources. The FDA's continuing efforts to come to grips with its regulatory responsibilities comprise a mini-history of American administrative law. Since the 1960's, regulation of food, drugs, and related products has presented some of the most challenging illustrations of the tense interplay between law and science. Because of the growing complexity of its responsibilities and the potential clash between public objectives, the FDA has been forced to experiment with a wide variety of innovative administrative procedures for deciding controversial law-science issues. The story of federal efforts to regulate the marketing of foods and drugs is fascinating as history in itself.
http://www.amazon.com/gp/product/1587780682/?tag=2022091-20
(This softbound book supplements Food and Drug, 3d, by Pet...)
This softbound book supplements Food and Drug, 3d, by Peter Barton Hutt, Richard A. Merrill, and Lewis A. Grossman. It is a compilation containing the statutes affecting food and drug law.
http://www.amazon.com/gp/product/1599414562/?tag=2022091-20
HUTT, Peter was born on November 16, 1934 in Buffalo, New York, United States. Son of Lester Ralph Hutt and Louise Rich Fraser.
Bachelor magma cum laude, Yale University, 1956. Bachelor of Laws, Harvard University, 1959. Master of Laws, New York University, 1960.
Associate Covington & Burling, Washington, 1960-1968, partner, 1968—1971, 1975—2004, senior counsel, since 2004. Chief counsel Food and Drug Administration, 1971-1975. Board director Livining Proof, Cambridge, Massachusetts, since 2007, CV Therapeutics Inc., Palo Alto, California, 2000—2008, Favrille, Inc., San Diego, 2003—2008, Momenta, Inc., Cambridge, Massachusetts, since 2001, Q Therapeutics, Salt Lake City, since 2002, Ista Pharmaceuticals, Inc., Irvine, California, since 2002, Pervasis Therapeutics, Inc., Boston, since 2004, Introgen Therapeutics, Inc., Houston, 2004—2008, Xoma, Inc., Berkeley, California, since 2005, California HealthCare Institute, San Diego, since 1996, Life Line Screening, Cleveland, since 2006, Concert Pharmaceuticals, Inc., Lexington, Massachusetts, since 2006, Endotis Pharma, Romainville, France, since 2008, Bind Bioscis.
Inc., Cambridge, since 2008, Seventh Sense Inc., Cambridge, Massachusetts, since 2008, Celera Corporation, Alameda, California, since 2008, Nana Medical Systems, Austin, Texas, since 2008, DBV Technologies, Paris, since 2009, Keck Graduate Institute Applied Life Science, Claremont, California, since 2007, Aeras Global Tuberculosis Vaccine Foundation, Rockville, Maryland, since 2006, DBV Technologies, Paris, since 2009, Selecta Bioscis., Inc., Watertown, Massachusetts, since 2010. Advisory committee to director National Institutes of Health, 1976—1981. Committee on research training National Academy of Sciences, 1976—1980.
Counsel to Alcoholic Beverage Medical Research Foundation, 1984—1985, chairman board director, 1986—1992. Member National Committee to Review Current Proceedings for Approval of New Drugs for Cancer and Acquired Immune Deficiency Syndrome, National Cancer Institute, 1988—1990. Member national board Scripps Clinic and Research Foundation, La Jolla, 1977—1985, 1990—1995.
Member international board Scripps Institutions of Medicine and Science, 1995—2002, Center for Study Drug Development, Tufts University Center, 1976—1999, Center for Advanced Studies, U.Va., 1982—2002, Institute for Health Policy Analysis, since 1982, American Council of Scientific and Health, since 2006, American Pharmaceutical Institute, Washington, 1988—1992. Committee on food laws and regulations Institute Food Technology. Advisory committee Progress and Freedom Foundation, 1994—1997.
Advisory board Frazier Healthcare Investments, Seattle, 1993—1999, Sprout Group, New York and Menlo Park, since 1993, Polaris Venture Partners, Waltham, since 1995, Kearny Venture Partners, San Francisco, since 2006, Vanguard Medica Ltd., Guildford, England, 1993—1999, Columbia University School Public Health, 1997—2004, Sherbrook Capital Health & Wellness Fund, Lexington, Massachusetts, since 1999, Burrill Neutraceuticals, San Francisco, since 2000, New Leaf Venture Partners, New York, Menlo Park, California, since 2005, Sirtris Phrams., Inc., Cambridge, Massachusetts, since 2006, Magen BioScis., Inc., Cambridge, 2006—2009, Aretais, Inc., since 2008, Gelesis Inc., since 2008, Yale School Public Health, New Haven, since 2011. Panel member United States Congressional Office Technology Assessment. Lecturer on food and drug law Harvard University, since 1994, Stanford University, 1998.
Panel on administrative restructuring National Institutes of Health, National Academy Public Administration, 2004—2006. Member working group Acquired Immune Deficiency Syndrome division National Institute Allergy and Infectious Diseases, 2005—2006. Member science board subcommittee on state of Food and Drug Administration science Food and Drug Administration, 2006—2007.
(This compilation includes the completely updated Federal ...)
(This compilation includes the completely updated Federal ...)
(Food and drug law deals with governmental attempts to pro...)
( Approximately 25 cents out of every dollar spent by Ame...)
(This softbound book supplements Food and Drug, 3d, by Pet...)
Author: (with Patricia Wald) Dealing with Drug Abuse, 1972, (with Richard Merrill, Lewis Grossman) Food and Drug Law, 2007, (with Bruce Kuhlik) Understanding Export Law, 1998. Editor-in-chief United States Food Labeling Law, since 1991. Contributing editor: Legal Times of Washington, 1978-1986.Member editorial board various journals. Editor: Food and Drug Law: An Electronic Book of Harvard Law School Student Papers, since 1994.
Board directors Sidwell Friends School, Washington, 1976-1984. Board directors Legal Action Center, New York City, 1976-2003, vice-chairman, 1984-1998. Board directors Foundation for biomedical Research, since 1976, vice chairman, since 1989.
Trustee Washington Lawyers Committee for Civil Rights and Urban Affairs, since 1976, Food and Drug Law Institute, 2001-2005. Board directors Society Risk Analysis, 1985-1988, 89-92, counsel, since 1992. Member visiting committee Harvard School Public Health, 1980-1986.
Fellow: Society Risk Analysis. Member: Institute Medicine of National Academy of Sciences (Development of Drugs and Vaccines Against Acquired Immune Deficiency Syndrome roundtable 1988-1994, board on health care services 1998—2002).
Research on the history of govt, regulation of food and drugs.
Children: Katherine Zurn, Peter Barton, Sarah Henderson, Everett Fraser.